NEW YORK – Biotech companies Frame Therapeutics and eTheRNA Immunotherapies said on Tuesday that they have had received a €1.9 million ($2.3 million) grant to jointly develop a kidney cancer vaccine.
The funds were awarded through Eurostars, a program funded by the European Union and the national budgets of 36 countries that aims to support innovative startups and small or medium-sized enterprises that are leveraging international collaboration in their R&D.